Entradas Etiquetadas :


Katherine Wilisch new member of QUIBIM team

A new ‘quibimer’ in our team

We are pleased to announce the incorporation of Mrs. Katherine Wilisch Ramírez as a new member of our team. Katherine is graduate in Biotechnology and Master in Human Genetics by the University of Valencia has recently joined to the QUIBIM team as General Coordination and CEO support. Katherine has a remarkable experience in the field of innovation and technology transfer. She previously was coordinator at the VIT salud network and at the Spanish Association of Scientific Entrepreneurs. She has collaborated in the organisation of more than 10 events related to health, technology and innovation. We welcome Katherine in our team and we wish her a brilliant future in QUIBIM. Enjoy this new experience of your life joining our great team and thank you for becoming a ‘quibimer’.

Katherine Wilisch new member of QUIBIM team

Katherine Wilisch new member of QUIBIM team

Summer School on Oncology Imaging Biomarkers

Oncology Imaging Biomarkers

Imaging biomarkers define objective quantitative characteristics extracted from medical images that are related to normal biological processes, clinical endpoints in diseases, or the response to treatment.

In order to develop an imaging biomarker, it is necessary to carry out a series of steps to validate its relation with the reality studied and to check its clinical and technical validity. As we published in 2012 (https://www.ncbi.nlm.nih.gov/pubmed/21733539) and later adopted by the European Society of Radiology (ESR) (https://www.ncbi.nlm.nih.gov/pubmed/23397519), these steps allow for an efficient way of adoption of imaging biomarkers either in clinical routine or clinical trials. This process includes defining tests for the concepts and mechanisms; obtaining standardized and optimized anatomic, functional, and molecular images; analyzing the data with computer models; displaying data appropriately; obtaining the appropriate statistic measures; and conducting tests on the principle, efficacy, and effectiveness. Although important advances are being developed nowadays in the field of image processing algorithms for the extraction of quantitative information from images, the integration of this information in clinical routine requires the existence of validated biomarkers, according to specific protocols for their analysis, in terms of the processing algorithms needed, the models applied and the way the results are generated.

All these topics will be addressed in the upcoming Summer School that we are organising from the 25th to 29th of next July in Valencia under the umbrella of the European Institute for Biomedical Imaging Research (EIBIR). In case you are interested please register to the course and you will enjoy an unforgettable week in Valencia.

Registrations at: http://www.eibir.org/scientific-activities/joint-initiatives/biomedical-image-analysis-platform/eibir-summer-school/2016-2/


EIBIR Summer School on Oncology Imaging Biomarkers Poster

EIBIR Summer School on Oncology Imaging Biomarkers